Lexaria Bioscience (LXRP) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock LXRP Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period LEXX: GLP-1-H25-5 Study CompleteJune 16 at 2:13 PM | msn.comHead-To-Head Review: NioCorp Developments (NASDAQ:NB) and Lexaria Bioscience (OTCMKTS:LXRP)June 15 at 1:37 AM | americanbankingnews.comLexaria Bioscience to Engage with Industry Leaders at BIO International ConventionJune 5, 2025 | tipranks.comLexaria Bioscience Stock Price, Quotes and Forecasts | NASDAQ:LEXXW | BenzingaMay 21, 2025 | benzinga.comLexaria Bioscience Corp.: Lexaria Provides Update on Material Transfer Agreement with Pharmaceutical CompanyMay 13, 2025 | finanznachrichten.deLexaria Advances Collaboration with Pharma Partner on Drug Delivery TechnologyMay 12, 2025 | tipranks.comLexaria Bioscience Corp.: Lexaria Announces Closing of $2 Million Registered Direct Offering of Common StockApril 28, 2025 | finanznachrichten.deLexaria Bioscience Secures $2 Million in Direct Stock OfferingApril 28, 2025 | tipranks.comLexaria Bioscience Secures $2 Million in Direct Stock OfferingApril 25, 2025 | tipranks.comLexaria Bioscience Corp.: Lexaria Announces $2 Million Registered Direct Offering of Common StockApril 25, 2025 | finanznachrichten.deLEXX: Second Quarter ResultsApril 24, 2025 | msn.comLexaria Bioscience Corp.: Lexaria's Human GLP-1 Study #5 Begins DosingApril 2, 2025 | finanznachrichten.deLexaria Bioscience announces PK results on DehydraTech-Tirzepatide oral capsulesMarch 19, 2025 | markets.businessinsider.comLexaria's DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly’s Injectable Zepbound(R)March 18, 2025 | finance.yahoo.comLexaria Bioscience Corp.: Lexaria's DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly's Injectable ZepboundMarch 18, 2025 | finanznachrichten.deLexaria Bioscience Corp.: Lexaria's Strategic Business Pursuit of DehydraTECH-LiraglutideFebruary 20, 2025 | finanznachrichten.deLexaria Bioscience stock hits 52-week low at $1.62February 11, 2025 | msn.comLexaria reports promising drug delivery study resultsJanuary 30, 2025 | msn.comLexaria CEO says FY25 R&D will ‘remain concentrated’ on GLP-1 investigationsJanuary 30, 2025 | markets.businessinsider.comLexaria Bioscience Strengthens GLP-1 Drug Delivery Focus and Expands Patent Portfolio in 2024January 30, 2025 | tipranks.comLexaria Bioscience price target lowered to $7 from $10 at H.C. WainwrightJanuary 24, 2025 | markets.businessinsider.comLexaria’s Human GLP-1 Study #5 Receives Independent Review Board ApprovalJanuary 17, 2025 | finance.yahoo.comLexaria’s human GLP-1 study 5 receives IRB approvalJanuary 17, 2025 | markets.businessinsider.comLexaria Bioscience Corp.: Lexaria's Human GLP-1 Study #5 Receives Independent Review Board ApprovalJanuary 15, 2025 | finanznachrichten.deLexaria Bioscience Advances with Human Study for Oral LiraglutideJanuary 15, 2025 | tipranks.comLexaria Bioscience announces partial results from GLP-1-H24-3 studyJanuary 15, 2025 | markets.businessinsider.comH.C. Wainwright maintains Buy rating on Lexaria Bioscience stockDecember 26, 2024 | uk.investing.comLexaria Bioscience Corp.: Esteemed Harvard Medical School Professor Dr. Michael Gibson Appointed Chief Medical Advisor at Lexaria BioscienceDecember 20, 2024 | finanznachrichten.deLexaria Bioscience’s Oral Tirzepatide Study ProgressesNovember 26, 2024 | markets.businessinsider.comPositive Partial 12-Week Body Weight Results from Lexaria’s GLP-1 Diabetes Animal StudyOctober 22, 2024 | finance.yahoo.comLexaria Updates Current GLP-1 MarketOctober 8, 2024 | finance.yahoo.comLexaria (NASDAQ: LEXX) Evaluating ‘More Effective, Tolerable’ Oral Delivery of GLP-1 DrugsSeptember 25, 2024 | theglobeandmail.comLexaria (NASDAQ: LEXX) Hires New CEO Amid Shift in Focus to Pharmaceutical CollaborationSeptember 24, 2024 | theglobeandmail.comLexaria (NASDAQ: LEXX) Eyeing Market Potential with Unique Delivery Platform, GLP-1 ProgramSeptember 17, 2024 | theglobeandmail.comLexaria Bioscience Corp.: Lexaria's Second GLP-1 Human Pilot Study Shows Zero Adverse Events in DehydraTECH-processed Rybelsus Oral CapsulesAugust 29, 2024 | finanznachrichten.deLexaria Bioscience Corp.: Positive 8-Week Body Weight Results from Lexaria's GLP-1 Diabetes Animal StudyAugust 25, 2024 | finanznachrichten.deTinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyeing Opportunity from First-Ever Work with Tirzepatide MoleculeAugust 16, 2024 | msn.comLexaria Bioscience (NASDAQ: LEXX) Exploring Alternative Diabetes and Obesity TreatmentsAugust 9, 2024 | theglobeandmail.comLEXX Stock Earnings: Lexaria Bioscience Misses EPS, Misses Revenue for Q3 2024July 12, 2024 | investorplace.comLexaria Bioscience (NASDAQ: LEXX) Selects CRO in Third GLP-1 Human Pilot StudyMay 24, 2024 | theglobeandmail.comLexaria Awards Contract For Third GLP-1 Human Pilot StudyMay 23, 2024 | finance.yahoo.comLexaria begins study on enhanced drug delivery technologyMay 19, 2024 | investing.comDosing Begins in Lexaria's Comprehensive GLP-1 Animal StudyMay 17, 2024 | finance.yahoo.comHere's Why We're Watching Lexaria Bioscience's (NASDAQ:LEXX) Cash Burn SituationMay 9, 2024 | finance.yahoo.comLexaria gets ethics board okay for oral GLP-1 studyApril 16, 2024 | msn.comLexaria (NASDAQ: LEXX) Hires Research Organization to Perform GLP-1 Human Pilot StudyMarch 27, 2024 | theglobeandmail.comLexaria appoints Nelson Cabatuan as CFOMarch 14, 2024 | msn.comLexaria Bioscience (NASDAQ: LEXX) Banking on DehydraTECH(TM) for Major 2024 GrowthMarch 11, 2024 | theglobeandmail.comLexaria Bioscience Corp.: Lexaria Announces Closing of $3.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesFebruary 16, 2024 | finanznachrichten.deWhy Lexaria Bioscience (LEXX) Shares Are MovingFebruary 15, 2024 | msn.com Get Lexaria Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for LXRP and its competitors with MarketBeat's FREE daily newsletter. Email Address LXRP Media Mentions By Week LXRP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LXRP News Sentiment▼0.000.90▲Average Medical News Sentiment LXRP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LXRP Articles This Week▼20▲LXRP Articles Average Week Get Lexaria Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for LXRP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Augusta Gold News Today American Lithium News Today American Lithium News Today Augusta Gold News Today Westwater Resources News Today Paramount Gold Nevada News Today Bunker Hill Mining News Today Pacific Booker Minerals News Today Wealth Minerals News Today Thunder Mountain Gold News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:LXRP) was last updated on 6/16/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexaria Bioscience Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lexaria Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LXRP Stock Free LXRP Stock Alerts